CytoCares (Shanghai) Inc.
PrivateLast Round
Strategic
Oct 23, 2025
Est. Valuation
$101.79M
Total Funding Raised
$23.71M
Company Overview
CytoCares (Shanghai) Inc. is a biotechnology company that develops first-in-class therapeutics for cancer and autoimmune disease treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoCares (Shanghai) Inc. Comparables
Compare CytoCares (Shanghai) Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chimagen Biosciences | 87% | |
| EvolveImmune Therapeutics | 78% | |
| Nanjing Leads Biolabs Co Ltd | 76% |
CytoCares (Shanghai) Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 23, 2025 | ||||
| Series A Extension | May 12, 2023 | ||||
| Series A | Oct 13, 2020 | ||||
| Pre Seed | Jan 2, 2020 | ||||
| Angel | Jun 29, 2016 |
CytoCares (Shanghai) Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shengshijing Asset Management Group | Series A |
| Tailong Investment | Series A Extension |
| Shenzhen Capital Group | Series A Extension |
| Shenzhen Capital Group | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2020
Raised Series A round with Shengshijing Asset Management Group.
- Jan 2, 2020
Completed a Pre Seed funding round.
CytoCares (Shanghai) Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CytoCares (Shanghai) Inc.'s valuation, stock price, and market status.
Is CytoCares (Shanghai) Inc. a public or private company?
CytoCares (Shanghai) Inc. is a private company.
What is the current stock price of CytoCares (Shanghai) Inc.?
CytoCares (Shanghai) Inc. is a private company, so its shares have no public market price. Caplight tracks CytoCares (Shanghai) Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CytoCares (Shanghai) Inc. worth (valuation)?
CytoCares (Shanghai) Inc.'s valuation is estimated at $101.8M based on funding round data.
Can I buy CytoCares (Shanghai) Inc. stock?
CytoCares (Shanghai) Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CytoCares (Shanghai) Inc.'s last funding round?
CytoCares (Shanghai) Inc.'s most recent funding round was Strategic on October 23, 2025.
Who are the main investors in CytoCares (Shanghai) Inc.?
Key investors in CytoCares (Shanghai) Inc. include Shengshijing Asset Management Group, Tailong Investment, Shenzhen Capital Group, Shenzhen Capital Group.
Will CytoCares (Shanghai) Inc. IPO soon?
No public IPO plans have been announced for CytoCares (Shanghai) Inc..
How can I track CytoCares (Shanghai) Inc. secondary market activity?
Caplight tracks bids, offers, and trades in CytoCares (Shanghai) Inc.'s shares on secondary markets.